Brokerages Set $4.00 Target Price for RTI Surgical Inc. (NASDAQ:RTIX)
Shares of RTI Surgical Inc. (NASDAQ:RTIX) have earned a consensus broker rating score of 3.00 (Hold) from the two analysts that provide coverage for the stock, Zacks Investment Research reports. Two research analysts have rated the stock with a hold recommendation. RTI Surgical’s rating score has declined by 50% in the last three months as a result of various analysts’ upgrades and downgrades.
Brokerages have set a one year consensus target price of $4.00 for the company and are predicting that the company will post $0.02 EPS for the current quarter, according to Zacks. Zacks has also given RTI Surgical an industry rank of 156 out of 265 based on the ratings given to its competitors.
Several analysts have commented on the stock. Zacks Investment Research upgraded shares of RTI Surgical from a “sell” rating to a “hold” rating in a report on Wednesday, September 28th. Craig Hallum lowered shares of RTI Surgical from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $6.00 to $4.00 in a report on Thursday, July 28th.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/07/brokerages-set-4-00-target-price-for-rti-surgical-inc-nasdaqrtix.html
Hedge funds have recently modified their holdings of the company. Schwab Charles Investment Management Inc. raised its position in RTI Surgical by 19.1% in the second quarter. Schwab Charles Investment Management Inc. now owns 224,600 shares of the company’s stock valued at $807,000 after buying an additional 36,002 shares during the last quarter. Numeric Investors LLC raised its position in RTI Surgical by 14.0% in the second quarter. Numeric Investors LLC now owns 68,196 shares of the company’s stock valued at $245,000 after buying an additional 8,400 shares during the last quarter. KCG Holdings Inc. acquired a new position in RTI Surgical during the second quarter valued at about $108,000. State Street Corp raised its position in RTI Surgical by 1.4% in the second quarter. State Street Corp now owns 964,124 shares of the company’s stock valued at $3,459,000 after buying an additional 13,223 shares during the last quarter. Finally, Spark Investment Management LLC raised its position in RTI Surgical by 16.2% in the second quarter. Spark Investment Management LLC now owns 216,100 shares of the company’s stock valued at $775,000 after buying an additional 30,100 shares during the last quarter. Institutional investors and hedge funds own 78.97% of the company’s stock.
RTI Surgical (NASDAQ:RTIX) traded down 0.97% on Friday, hitting $3.07. The company had a trading volume of 18,353 shares. The company has a market capitalization of $177.36 million, a P/E ratio of 43.24 and a beta of 1.57. The stock’s 50-day moving average price is $3.19 and its 200 day moving average price is $3.62. RTI Surgical has a one year low of $2.81 and a one year high of $5.56.
RTI Surgical (NASDAQ:RTIX) last posted its earnings results on Wednesday, July 27th. The company reported ($0.05) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.03 by $0.08. The business earned $67.60 million during the quarter, compared to the consensus estimate of $66.52 million. RTI Surgical had a return on equity of 6.51% and a net margin of 2.80%. The firm’s revenue for the quarter was down 5.6% compared to the same quarter last year. During the same period in the previous year, the business earned $0.04 earnings per share. On average, analysts expect that RTI Surgical will post $0.10 EPS for the current fiscal year.
RTI Surgical Company Profile
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.